Bragar Eagel & Squire, P.C. Files Class Action Lawsuit Against Elanco Animal Health!
- A class action lawsuit has been filed against Elanco Animal Health Incorporated for misleading statements.
- The lawsuit represents investors who acquired Elanco securities during a specified period.
- Investors are encouraged to contact Bragar Eagel & Squire, P.C. for more information and potential participation.
On November 6, 2024, Bragar Eagel & Squire, P.C. announced a class action lawsuit against Elanco Animal Health Incorporated in the United States District Court for the District of Maryland. The lawsuit is on behalf of investors who purchased Elanco securities between November 7, 2023, and June 26, 2024. The allegations include that the company made false and misleading statements regarding its business operations and financial prospects related to the safety and approval timeline of its products, Zenrelia and Credelio Quattro. The lawsuit claims that Elanco misled investors about the safety of Zenrelia and its ability to meet set timelines for product launches. The firm encourages affected investors to contact them for more information and to participate in the actions against the company.